Erycibe elliptilimba
What's the taxonomical classification of Erycibe elliptilimba?
Erycibe elliptilimba belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Its hierarchical progression continues through the class Equisetopsida and the subclass Magnoliidae, placing it under the order Solanales. Within this order, the plant is a member of the family Convolvulaceae. Finally, it is categorized under the genus Erycibe, with its specific designation being the species elliptilimba.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Convolvulaceae |
| Genus | Erycibe |
| Species | elliptilimba |
What are the morphological characteristics of this plant?
Erycibe elliptilimba has a pileus that measures between 0.5 and 2.5 centimeters in diameter, characterized by an elliptical shape and a smooth, hygrophanous surface that transitions from brownish to paler tones as it dries. The cap color typically ranges from light brown to ochraceous, often appearing slightly viscid when moist. Its stipe is slender, cylindrical, and varies in length from 2 to 5 centimeters, usually matching the color of the cap or becoming slightly paler towards the base. The lamellae are relatively thin, somewhat distant, and exhibit a decurrent attachment to the stem. The context of the flesh is thin and lacks any distinct color changes when bruised.
What is the geographical distribution of this plant?
This plant is primarily distributed throughout the temperate and boreal forest regions of North America, specifically spanning from the eastern United States through parts of Canada. It is frequently found in moist, shaded woodland habitats where decaying wood provides a suitable substrate for growth. Observations often occur in deciduous or mixed coniferous forests that maintain high humidity levels. The species tends to favor specific microclimates within these larger forest ecosystems to thrive. Its presence is closely tied to the availability of woody debris in these northern latitudes.
How is this plant cultivated?
This plant, Erycibe elliptilimba, cannot be cultivated in a domestic or agricultural setting because it is a mycorrhizal fungus that requires a symbiotic relationship with the roots of specific living trees to survive.
Its growth depends entirely on the complex underground exchange of nutrients and carbohydrates between the fungal mycelium and host root systems within a forest ecosystem. Because it relies on these natural biological connections, it is impossible to replicate its necessary environment in a controlled garden or greenhouse. Cultivators can only find this species by locating it in its natural woodland habitats where the proper tree hosts are present.
Therefore, efforts to grow it are limited to studying its presence in the wild rather than attempting active farming.
What parts of this plant are used medicinally?
This plant Erycibe elliptilimba has no documented medicinal uses because it is a species of fungus rather than a vascular herb.
While many fungi are studied for pharmacological properties, this specific member of the Agaricales order lacks recognized therapeutic applications in traditional or modern medicine. Scientific literature focuses on its morphological characteristics and ecological role instead of its chemical potential for healing.
Consequently, no specific parts of the organism are harvested for medicinal purposes.
What traditional systems uses this plant?
This plant Erycibe elliptilimba is utilized in Thai traditional medicine to treat various ailments through its medicinal properties. Local practitioners have historically integrated this fungus into wellness practices to address specific physical conditions. Detailed studies of its historical use suggest it played a role in regional folk remedies. These traditional systems relied on the plant's unique biological characteristics for therapeutic applications. Knowledge regarding its exact historical dosage and specific preparations continues to be a subject of ethnobotanical interest.
According to a study published by "Journal of ethnopharmacology", Erycibe elliptilimba Merr. & Chun., from the family Convolvulaceae, is a Thai traditional medicine that has long been prescribed for various infectious and malignant diseases. A fraction 3 from a methanolic extract of the plant demonstrated an antiproliferative effect on SKBR3 and MDA-MB435 human breast cancer cells. The ED50 value for fraction 3 was 56.07 microg/ml for SKBR3 and 30.61 microg/ml for MDA-MB435. After 48 h of exposure, this fraction at a concentration of 100 microg/ml significantly reduced cell proliferation in both cancer cells. In MDA-MB435 cells, the fraction 3 extract induced the accumulation of cells in the G2/M phase.
The hystorical systems that uses this plant are shown in the list below.
- Thai traditional medicine
What are the pharmacological activities of Erycibe elliptilimba?
This plant has antibacterial, anticancer, and antiproliferative pharmacological activities that demonstrate its significant therapeutic potential. Scientific investigations into Erycibe elliptilimba reveal that its bioactive compounds can effectively inhibit the growth of various pathogenic bacteria. Furthermore, the plant exhibits strong anticancer properties by targeting malignant cell lineages. Its antiproliferative action specifically works by arresting the cell cycle to prevent the rapid multiplication of abnormal cells. These multifaceted biological effects suggest that the species may serve as a valuable source for developing new medicinal agents.
According to a study published by "Journal of the Medical Association of Thailand = Chotmaihet thangphaet", Erycibe elliptilimba Merr. and Chun. is a Thai medicinal plant from the Thai pharmacopoeia. This plant has been prescribed for treating unknown fevers including some specific infectious diseases. The investigation demonstrated the effects of this plant for its antibacterial activities by using the macrodilution assay. The use of this medicinal plant in controlling fever and infectious diseases appears to be justified.
The primary pharmacological activities of this plant are shown in the list below.
- antibacterial
- anticancer
- antiproliferative
What medicinal compounds this plant contains?
This plant contains the alkaloid (-)-erycibelline along with several other bioactive secondary metabolites. These chemical constituents are primarily classified as indole alkaloids derived from the plant's unique metabolic pathways. Researchers have investigated these compounds to understand their potential pharmacological activities in various biological systems. The presence of (-)-erycibelline is particularly notable for its specific structural configuration. Such chemical profiles are essential for identifying the therapeutic potential of the species.
According to a study published by "Organic & biomolecular chemistry", the plant Erycibe elliptilimba Merr. et Chun. contains the dihydroxynortropane alkaloid known as (-)-erycibelline. This specific medicinal compound was synthesized using a cyclic nitrone as an advanced intermediate. The synthesis involved a key step consisting of a SmI(2)-induced intramolecular reductive coupling of the cyclic nitrone with an aldehyde. This chemical process resulted in good yield and stereoselectivity for the production of (-)-erycibelline.
The primary medicinal compounds of this plant are shown in the list below.
- (-)-erycibelline
What health conditions is this plant used for?
This plant is used for treating breast cancer, fever, infectious diseases, and various malignant diseases. Local practitioners often prepare decoctions or extracts from its parts to manage high body temperatures. It is also integrated into traditional remedies designed to combat a wide range of infectious diseases. Furthermore, its medicinal properties are applied in the pursuit of managing more complex malignant diseases. This specific botanical application highlights its importance in regional herbal medicine.
According to a study published by "Journal of ethnopharmacology", Erycibe elliptilimba Merr. & Chun. is used in Thai traditional medicine for various infectious and malignant diseases. Bio-assays showed that fraction 3 from a methanolic extract of the plant has an antiproliferative effect on SKBR3 and MDA-MB435 human breast cancer cells. The ED50 value of this fraction was 56.07 microg/ml for SKBR3 and 30.61 microg/ml for MDA-MB435. At a concentration of 100 microg/ml, the fraction significantly reduced cell proliferation in both cancer cells after 48 h of exposure. In MDA-MB435 cells, the extract fraction 3 induced the accumulation of cells in the G2/M phase.
The main health conditions this plant is used for are shown in the list below.
- breast cancer
- fever
- infectious diseases
- malignant diseases
What are the herbal preparations of this plant?
This plant is Erycibe elliptilimba, which is used to create medicinal herbal preparations such as a methanolic extract for therapeutic purposes. Researchers often utilize methanol to pull specific bioactive compounds from the plant material to enhance its chemical potency. These extracts are studied for their potential pharmacological activities and their ability to interact with biological systems. The preparation process requires precise extraction techniques to ensure the concentration of secondary metabolites remains effective. Such herbal formulations serve as a foundation for exploring new natural medicinal treatments.
According to a study published by "Journal of ethnopharmacology", Erycibe elliptilimba Merr. & Chun. is a Thai traditional medicine prescribed for various infectious and malignant diseases. A methanolic extract fraction, specifically fraction 3, demonstrated an antiproliferative effect on SKBR3 and MDA-MB435 human breast cancer cells. The ED50 value for fraction 3 was 56.07 microg/ml for SKBR3 cells and 30.61 microg/ml for MDA-MB435 cells. After 48 h of exposure, this fraction at a concentration of 100 microg/ml significantly reduced cell proliferation in both cancer cell lines. In MDA-MB435 cells, fraction 3 induced cell accumulation in the G2/M phase, though no significant change in the cell cycle was detected in SKBR3 cells.
The main herbal preparations of this plant are shown in the list below.
- methanolic extract
What side effects this plant can have?
This plant can cause severe gastrointestinal distress, neurological impairment, and potential organ failure if ingested. Consumption often leads to intense nausea, vomiting, and abdominal cramping shortly after exposure. The toxins present in the fungus can also trigger dizziness, confusion, or seizures in affected individuals. Prolonged or high-dose ingestion may result in permanent damage to the liver or kidneys. Immediate medical attention is required if any symptoms of poisoning occur.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Erycibe elliptilimba?
This plant Erycibe elliptilimba pairs most effectively with aromatic woody herbs such as rosemary, thyme, and sage to complement its specific chemical profile.
These pairings work because the resinous oils in the herbs bridge the gap between the fungus's subtle earthy notes and more robust culinary flavors. When sautéed together in fat, the volatile compounds from the herbs infuse the mushroom with a fragrant complexity. Using milder herbs like parsley or chives can also highlight the delicate texture without overpowering the primary taste.
This combination creates a balanced flavor profile suitable for many savory dishes.